8 Amendments of Esther DE LANGE related to 2020/2071(INI)
Amendment 15 #
Motion for a resolution
Citation 23 a (new)
Citation 23 a (new)
- having regard to the Commission Guidance concerning foreign direct investment and free movement of capital from third countries, and the protection of Europe’s strategic assets in the context of the COVID-19 emergency, ahead of the application of Regulation (EU) 2019/452 (FDI Screening Regulation), which will be fully operational as from 11 October 2020,
Amendment 66 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas medicine shortages can lead to possible delays in patients’ treatment, to the need to switch to alternative therapies that could be less effective, to adverse effects and adherence problems or even life threat when a shortage concerns essential medicines;
Amendment 186 #
Motion for a resolution
Recital J a (new)
Recital J a (new)
Ja. whereas the COVID-19 emergency has highlighted the increased risk of attempts to acquire healthcare capacities via foreign direct investment and the need to preserve and enhance the sharing of such precious capacities within the single market;
Amendment 239 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Stresses the need for health policies to focus on patients’ interests and for closer cooperation between Member States; Notes that the interest and safety of patients should be at the heart of European health policy;
Amendment 347 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Urges the Commission and the Member States to introduce incentives supporting the diversification of supply, such as tax and financial incentives in return for appropriate commitments and to authorise state aid to encourage producers to locate their operations in Europe, from compound manufacturing to packaging and distribution; emphasises the strategic significance of this sector and the importance of investing in European companies, in the interests of resource diversification;
Amendment 462 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11a. Calls on the Commission and the Member States to screen foreign direct investments in medicines manufacturing plants as part of Europe's critical health infrastructure.
Amendment 476 #
Motion for a resolution
Paragraph 11 b (new)
Paragraph 11 b (new)
11b. Calls on the Commission to increase its involvement in supporting critical health infrastructure protection in Member States and to start applying the European Programme for Critical Infrastructure Protection (EPCIP) to the health infrastructure sector;
Amendment 660 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Calls for structural cooperation in the field of pharmaceutical policy between EU Member States, respecting the competences between the national and EU-level, through transparent, and where possible joint, price negotiations for medicines, especially for orphan medicines;